Canaccord Genuity Reiterates a 'Buy' on Amarin Corporation (AMRN); AMR101 Benefits Diabetics in ANCHOR
Tweet Send to a Friend
Canaccord Genuity reiterates a 'Buy' on Amarin Corporation (NASDAQ: AMRN) price target of $25.00.
Analyst, Ritu Baral, said, "Reiterate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Ritu Baral, said, "Reiterate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
